Scientific Journals
News and Features
AAPS Meetings and Education
  Products and Services
  AAPS Member Services
  AAPS Press Room
  Marketing Opportunities
  Affiliated Organizations
  Join AAPS

View PDF Version 
View Small Version
View Full Version
View Tables & Figures
Abstract
Introduction
Materials and Methods
Results
Discussion
Conclusion
References

Scientific Journals: AAPS PharmSci

Rabel SR, Patel M, Sun S and Maurin MB Electronic and Resonance Effects on the Ionization of Structural Analogues of Efavirenz AAPS PharmSci 2001; 3 (4) article 28 (https://www.pharmsci.org/scientificjournals/pharmsci/journal/01_28.html).

Electronic and Resonance Effects on the Ionization of Structural Analogues of Efavirenz

Submitted: July 25, 2001; Accepted: November 13, 2001; Published: November 20, 2001

Shelley R. Rabel1, Mona Patel2, Sophie Sun1 and Michael B. Maurin1

1Pharmacy R&D, The DuPont Pharmaceuticals Company, Wilmington, DE 19880-0400

2Chemical and Physical Sciences, The DuPont Pharmaceuticals Company, Wilmington, DE 19880-0400

Correspondence to:
Shelley R. Rabel
Telephone: 302-695-3188
Facsimile: 302-695-1460
E-mail: shelley.rabel@bms.com

Keywords:
pKa
Ionization
Benzoxazinone
Carbamate
Solubility
Efavirenz Analogues

Abstract

The solubility of 4 analogues of efavirenz was studied as a function of pH. The study evaluated the ionization behavior and determined the relative contribution of electronegative substituents versus resonance effects on the pKa value of the cyclic carbamate. The most profound lowering effect on the pKa was due to the presence of multiple electronegative substituents and in particular the trifluoromethyl and acetylene groups. The presence of chlorine on the benzoxazinone ring was found to have a slight impact on the pKa , although to a lesser extent. In the absence of any functional groups on the benzoxazinone ring system, the pKa shifted to a value of 13.2, which is 3 pH units above that of efavirenz and more closely correlates with typical literature values for cyclic carbamates.


Introduction

Efavirenz (Figure 1 ) is a non-nucleoside reverse transcriptase inhibitor that has been approved by the Food and Drug Administration for the treatment of human immunodeficiency virus. The pKa of efavirenz was determined previously by spectrophotometric and pH-solubility studies and found to be 10.2, which is anomalous with respect to typical ionization behavior of cyclic carbamates1 . Although the basis for the lower-than-anticipated pKa value was not understood completely, it was postulated that electronic withdrawing effects of the electronegative substituents and/or the potential for delocalization of the charge on the benzoxazinone ring system could be responsible for the lowering of the pKa .

The objective of the current work was to address the contributions of electronegative and resonance effect through the study of 4 efavirenz analogs (Figure 1 ) to more definitively assess the relative influence of these factors on the ionization behavior of the carbamate of the benzoxazinone.


Materials and Methods

Materials

All 4 structural analogues of efavirenz were synthesized by DuPont Pharmaceuticals Chemical and Physical Sciences Department (Wilmington, DE). Water was purified by a MilliQ-PlusTM ultra-pure water system (Millipore, Bedford, MA) with a specific resistance of >18 MΩ. All solvents were of high-performance liquid chromatography (HPLC) grade (EM Science, Gibbstown, NJ). Standard solutions of HCl and NaOH were purchased from VWR Scientific (West Chester, PA).

Chromatographic Method

Chromatographic analysis of efavirenz analogues was done using an isocratic reversed-phase HPLC method and UV detection at 250 nm. Separations were performed on a ZorbaxTM RX -C8 column (4.6 x 250 mm) (Mac-Mod Analytical, Chadds Ford, PA) maintained at 35°C. The mobile phase consisted of 60% acetonitrile and 0.1% trifluoroacetic acid in water (vol/vol) at a flow rate of 0.6 mL/min. A vax-based data system, Multichrom2 (Fisons Instruments, Danvers, MA), was used to acquire data. Quantitation was based on the area response curve from standards prepared just prior to analysis.

Solubility Determinations

The solubility as a function of pH was determined for each compound by placing excess solid in a suitable container and adding deionized water that had previously been adjusted to the desired pH value by the addition of HCl or NaOH. The samples were rotated end to end for a minimum of 1 hour; previous experiments had demonstrated this was adequate time for equilibration. The use of short equilibration times minimized the hydrolysis of the carbamate at the extreme pH conditions. The equilibrated suspensions were passed through 0.45-µm Whatman autovial (Teflon) syringeless filter devices (VWR Scientific). The first portion of the filtrate was discarded to ensure saturation of the filter, and the remaining filtrate was used for pH determination and diluted as necessary for HPLC analysis. The intrinsic solubility was determined by taking the average solubility over the pH range where only the un-ionized species was present.


Results

The solubility profiles for the 4 efavirenz analogues are shown in Figures 2 to 5 . All profiles are consistent with that of efavirenz, in which the carbamate undergoes deprotonation at high pH values to form a negatively charged species with increased solubility due to the ionization of the weak acid. Employing the same ionic equilibria previously used to determine the pKa of efavirenz1 , the data may be plotted according to equation 1:

....................(1)

where S T represents the total solubility measured at any given pH, [AH ] represents the solubility of the neutral species (intrinsic solubility), K a is the ionization constant and is equal to the slope of the line, and [H + ] is the hydrogen ion concentration at each pH value. The data for each analogue were plotted according to equation 1. Table 1 summarizes the results of the linear regression analysis that was performed on all 4 analogues. Theoretical solubility curves based on the intrinsic solubility values and experimentally determined pKa of each compound are shown in Figures 2 to 5 and were in excellent agreement with experimental results.


Discussion

Four analogues of efavirenz were studied to determine the relative contributions of electronegative substituents and that of delocalization effects through resonance on the ionization behavior of the carbamate functional group of the benzoxazinone. The electronegative atoms and functional groups present on efavirenz and the selected analogues are listed in Table 2 along with their assigned electronegativity values. The impact of the electronegative chlorine atom positioned directly on the benzoxazinone ring was evaluated by substituting a fluorine atom (Compound I), which resulted in a decrease in the pKa of 0.6 pH units. This result is consistent with an increase in the electronegativity of the fluorine atom compared to that of the chlorine and therefore increased stabilization of the negatively charged species. Conversely, the pKa of the des-chloro analogue (Compound II) increased by only 0.2 pH units, suggesting that the chlorine alone has a minimal influence on the pKa .

The trifluoromethyl substituent has an electronegativity value intermediate to that of chlorine and fluorine. Replacement of the trifluoromethyl with a methyl group (Compound III) resulted in an increase in the pKa by 1.3 pH units. The significant influence of this group may be due to its close proximity to the ionizable site as well as the larger difference in electronegativity values between the trifluoromethyl and methyl groups.


Conclusion

The influence of delocalization through resonance effects was evaluated in the absence of inductive effects by studying Compound IV, in which all substituents on the benzoxazinone ring were absent. The pKa of Compound IV increased by 3 pH units over that of efavirenz, suggesting that the electron-withdrawing substituents as a whole contribute to the lowering of the pKa to a much greater extent than resonance effects. The correlation between the ionization behavior and electronegativity is illustrated in Figure 6 . The total electronegative contributions from all substituents on each compound on the benzoxazinone ring are plotted against the pKa . In particular, the absence of the trifluoromethyl and acetylene groups with electronegativity values of 3.0 and 3.3, respectively, appear to have a profound impact on the ionization behavior of efavirenz. Delocalization of charge over a relatively small benzoxazinone ring system does not play a large role in the unusually low pKa value of this particular series. Rather, the absence of the electronegative substituents results in a pKa that bears closer resemblance to values reported in the literature (>13) for cyclic carbamates 2,3 . Efavirenz represents a unique case where the presence of multiple electronegative substituents near to the ionizable carbamate of the benzoxazinone significantly alters the ionization behavior of this compound.


References

1. Rabel SR, Maurin MB, Rowe SM, Hussain M. Determination of the pKa and pH-solubility behavior of an ionizable cyclic carbamate, (S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one (DMP 266). Pharm Dev Tech. 1996;1:91-95. [PUBMED]

2. Bergon M, Bonafos M, Calmon JP. Kinetics of barban dechlorination in an alkaline medium. Agric Biol Chem. 1980;44:1237-1240.

3. Bergon M, Calmon JP. Structure-reactivity relationships in the hydrolytic degradation of propham, chloropropham, swep and related carbamates. J Agric Food Chem. 1983;31:738-743.

4. Carey FA, Sundberg RJ. Advanced Organic Chemistry, 2nd ed. New York: Plenum Press; 1984.

CURRENT ARTICLES
CONTENTS
    -Volume 4 Issue 4
    -Volume 4 Issue 3
    -Volume 4 Issue 2
    -Volume 4 Issue 1
    -Volume 3 Issue 4
    -Volume 3 Issue 3
    -Volume 3 Issue 2
    -Volume 3 Issue 1
    -Volume 2 Issue 4
    -Volume 2 Issue 3
    -Volume 2 Issue 2
    -Volume 2 Issue 1
    -Volume 1 Issue 4
    -Volume 1 Issue 3
    -Volume 1 Issue 2
    -Volume 1 Issue 1
SPECIAL ISSUES
SEARCH
Editorial Boards
Instructions to Authors
RESOURCES
    -Online Review System
    -About AAPS PharmSci
    -Calls for Papers
    -F.A.Q.
Contact Us!